Dr. Tami Brutman-Barazani is the head of the clinical studies team at the National Hemophilia Center and Thrombosis Institute in Tel Hashomer, Israel. Dr. Brutman-Barazani received her Ph.D. degree in Biology from Bar Ilan University (she was awarded a scholarship for excellent students). She joined the National Hemophilia Center in 2009 and has been responsible for all the clinical trials in the field of hemophilia and thrombosis. Dr. Brutman-Barazani leads a professional team of study coordinators and, in the last 12 years, she has been involved in dozens of international multicenter hemophilia studies, including pharmacokinetic studies. Dr. Brutman-Barazani was the leading staff member during three FDA inspections (September 2012, May 2015, and December 2019), which were successful, with the result of NAI. In addition, Dr. Brutman-Barazani is involved in writing grant proposals and is the author of a dozen publications, including original research manuscripts published in high-impact journals and abstracts presented at many international scientific meetings. She has served as an invited speaker at several research meetings and takes part in the international advisory board of nurses and study coordinators.